Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations.


Journal

HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392

Informations de publication

Date de publication:
04 2020
Historique:
accepted: 11 10 2019
pubmed: 16 11 2019
medline: 28 9 2021
entrez: 16 11 2019
Statut: ppublish

Résumé

Elite controllers (ECs), viraemic controllers (VCs), and long-term nonprogressors (LTNPs) control HIV viral replication or maintain CD4 T-cell counts without antiretroviral therapy, but may have increased cardiovascular disease (CVD) risk compared to HIV-uninfected persons. We evaluated subclinical carotid and coronary atherosclerosis and inflammatory biomarker levels among HIV controllers, LTNPs and noncontrollers and HIV-uninfected individuals in the Multicenter AIDS Cohort Study (MACS) and the Women's Interagency HIV Study (WIHS). We measured carotid plaque presence and common carotid artery intima-media thickness (IMT) in 1729 women and 1308 men, and the presence of coronary artery calcium and plaque in a subgroup of men. Associations between HIV control category and carotid and coronary plaque prevalences were assessed by multivariable regression analyses adjusting for demographics and CVD risk factors. Serum inflammatory biomarker concentrations [soluble CD163 (sCD163), soluble CD14 (sCD14), galectin-3 (Gal-3), galectin-3 binding protein (Gal-3BP) and interleukin (IL)-6] were measured and associations with HIV control category assessed. We included 135 HIV controllers (30 ECs) and 135 LTNPs in the study. Carotid plaque prevalence and carotid IMT were similar in HIV controllers, LTNPs and HIV-uninfected individuals. HIV controllers and LTNPs had lower prevalences of carotid plaque compared to viraemic HIV-infected individuals. The prevalence of coronary atherosclerosis was similar in HIV controllers/LTNPs compared to HIV-uninfected and viraemic HIV-infected men. Controllers and LTNPs had higher concentrations of sCD163 and sCD14 compared to HIV-uninfected persons. Subclinical CVD was similar in HIV controllers, LTNPs and HIV-uninfected individuals despite elevated levels of some inflammatory biomarkers. Future studies of HIV controllers and LTNPs are needed to characterize the risk of CVD among HIV-infected persons.

Identifiants

pubmed: 31729142
doi: 10.1111/hiv.12820
pmc: PMC7069771
mid: NIHMS1054831
doi:

Substances chimiques

Antigens, CD 0
Antigens, Differentiation, Myelomonocytic 0
Biomarkers 0
CD14 protein, human 0
CD163 antigen 0
Lipopolysaccharide Receptors 0
Receptors, Cell Surface 0
Calcium SY7Q814VUP

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

217-227

Subventions

Organisme : NIAID NIH HHS
ID : U01 AI103397
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : UM1-AI-35043
Pays : International
Organisme : NHLBI NIH HHS
ID : R01 HL095140
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-35042
Pays : International
Organisme : NIAID NIH HHS
ID : K24 AI120834
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI035043
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103401
Pays : United States
Organisme : NHLBI NIH HHS
ID : 5R01 HL095126
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-103401
Pays : International
Organisme : NIAID NIH HHS
ID : U01 AI035042
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI140789
Pays : United States
Organisme : Southern California WIHS
ID : U01-HD-032632
Pays : International
Organisme : NCRR NIH HHS
ID : UL1 RR025005
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-042590
Pays : International
Organisme : NIAID NIH HHS
ID : U01 AI031834
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-103408
Pays : International
Organisme : NCATS NIH HHS
ID : UL1 TR001079
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-035004
Pays : International
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-35041
Pays : International
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-034989
Pays : International
Organisme : NIAID NIH HHS
ID : U01 AI035004
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146208
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01-HL-095140
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-35039
Pays : International
Organisme : NHLBI NIH HHS
ID : R21 HL120394
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034989
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01-HL-137557
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000124
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126543
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095126
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1-TR000004
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL083760
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132794
Pays : United States
Organisme : NCRR NIH HHS
ID : UL1 RR 025005
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : P30-AI-050410
Pays : International
Organisme : NIAID NIH HHS
ID : U01 AI035041
Pays : United States
Organisme : NHLBI NIH HHS
ID : R21-HL-120394
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-103397
Pays : International
Organisme : NHLBI NIH HHS
ID : R01 HL095129
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1-TR000124
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034994
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146201
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1-TR000454
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG059505
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-103390
Pays : International
Organisme : NCATS NIH HHS
ID : UL1 TR000454
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146193
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01-HL-140976
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL140976
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-034994
Pays : International
Organisme : NHLBI NIH HHS
ID : U01 HL146204
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146202
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-031834
Pays : International
Organisme : NIAID NIH HHS
ID : U01 AI035040
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103390
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI034993
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01-HL-126543
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL146240
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-35040
Pays : International
Organisme : NCATS NIH HHS
ID : UL1 TR000004
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI035039
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI103408
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01-HL-083760
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01-HL-132794
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1-TR 001079
Pays : United States
Organisme : National Institute of Allergy and Infectious Diseases
ID : U01-AI-034993
Pays : International
Organisme : NIAID NIH HHS
ID : P30 AI050410
Pays : United States
Organisme : NHLBI NIH HHS
ID : K01 HL137557
Pays : United States
Organisme : NICHD NIH HHS
ID : U01 HD032632
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI042590
Pays : United States

Informations de copyright

© 2019 British HIV Association.

Références

AIDS. 2009 Jun 1;23(9):1059-67
pubmed: 19390417
J Infect Dis. 2008 Jan 1;197(1):126-33
pubmed: 18171295
Immunity. 2007 Sep;27(3):406-16
pubmed: 17892849
Open Forum Infect Dis. 2015 Jan 13;2(1):ofu117
pubmed: 25884005
Atherosclerosis. 2012 Jan;220(1):128-33
pubmed: 21764060
AIDS. 2018 Oct 23;32(16):2393-2403
pubmed: 30102657
JAMA. 2012 Jul 25;308(4):379-86
pubmed: 22820791
J Infect Dis. 2009 Dec 1;200(11):1714-23
pubmed: 19852669
N Engl J Med. 2007 Apr 26;356(17):1723-35
pubmed: 17460226
PLoS One. 2014 Jan 28;9(1):e86719
pubmed: 24489776
J Infect Dis. 2009 Dec 1;200(11):1636-8
pubmed: 19852668
Clin Chest Med. 2013 Jun;34(2):181-90
pubmed: 23702169
J Infect Dis. 2008 Feb 15;197(4):563-71
pubmed: 18275276
Clin Diagn Lab Immunol. 2005 Sep;12(9):1013-9
pubmed: 16148165
J Am Heart Assoc. 2016 Jun 27;5(6):
pubmed: 27353609
AIDS. 2012 Nov 28;26(18):2409-12
pubmed: 23032411
AIDS. 2010 Jan 16;24(2):243-53
pubmed: 19996940
Front Immunol. 2013 Mar 01;4:58
pubmed: 23459797
J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):334-40
pubmed: 22878421
N Engl J Med. 1998 Mar 26;338(13):853-60
pubmed: 9516219
N Engl J Med. 2008 Mar 27;358(13):1336-45
pubmed: 18367736
J Infect Dis. 2010 Feb 1;201(3):318-30
pubmed: 20039804
J Infect Dis. 2011 Oct 15;204(8):1227-36
pubmed: 21917896
AIDS. 2008 Aug 20;22(13):1589-99
pubmed: 18670218
Circulation. 2007 Jan 30;115(4):459-67
pubmed: 17242284
N Engl J Med. 2006 Nov 30;355(22):2283-96
pubmed: 17135583
J Acquir Immune Defic Syndr. 2012 Apr 1;59(4):368-75
pubmed: 22240460
Anadolu Kardiyol Derg. 2013 May;13(3):207-14
pubmed: 23376648
J Virol. 2009 Jan;83(1):329-35
pubmed: 18945778
AIDS. 2009 Jun 1;23(9):1163-9
pubmed: 19444075
Clin Infect Dis. 2015 Aug 15;61(4):640-50
pubmed: 25904369
Circulation. 1975 Apr;51(4 Suppl):5-40
pubmed: 1116248
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
Clin Infect Dis. 2016 Jul 15;63(2):249-56
pubmed: 27118787
J Virol. 2005 Nov;79(22):14169-78
pubmed: 16254352
AIDS. 2003 Nov 21;17(17):2479-86
pubmed: 14600519
Am J Epidemiol. 1987 Aug;126(2):310-8
pubmed: 3300281
AIDS. 2008 Aug 20;22(13):1615-24
pubmed: 18670221
J Infect Dis. 2015 Apr 15;211(8):1219-28
pubmed: 25362192
J Infect Dis. 2017 May 1;215(9):1352-1361
pubmed: 28199691
Arterioscler Thromb Vasc Biol. 2014 May;34(5):1085-92
pubmed: 24651679
J Infect Dis. 2014 Mar;209(6):931-9
pubmed: 24185941
J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12
pubmed: 17456578
HIV Med. 2013 Jul;14(6):385-90
pubmed: 23332012
J Infect Dis. 2012 Nov 15;206(10):1558-67
pubmed: 23066162
Ann Intern Med. 2014 Apr 1;160(7):458-67
pubmed: 24687069
Am J Epidemiol. 2013 Jan 15;177(2):116-25
pubmed: 23287403
AIDS. 2015 Nov 28;29(18):2427-34
pubmed: 26558542

Auteurs

R M Brusca (RM)

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

D B Hanna (DB)

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.

N I Wada (NI)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

J N Blankson (JN)

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

M D Witt (MD)

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.

L P Jacobson (LP)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

L Kingsley (L)

University of Pittsburgh, Pittsburgh, PA, USA.

F J Palella (FJ)

Northwestern University, Chicago, IL, USA.

M Budoff (M)

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.

T T Brown (TT)

Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

K Anastos (K)

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Department of Medicine, Montefiore Medical Center, Bronx, NY, USA.

J M Lazar (JM)

Department of Medicine, SUNY-Downstate Medical Center, Brooklyn, NY, USA.

W J Mack (WJ)

Preventive Medicine, University of Southern California, Los Angeles, CA, USA.

P Bacchetti (P)

Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA.

P C Tien (PC)

Department of Medicine and Clinical Pharmacy, University of California, San Francisco, CA, USA.
Department of Veterans Affairs Medical Center, San Francisco, CA, USA.

Y Golzar (Y)

Cook County Health and Hospital System, Chicago, IL, USA.

M Plankey (M)

Department of Medicine, Division of Infectious Diseases, Georgetown University Medical Center, Washington, DC, USA.

E Golub (E)

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

R C Kaplan (RC)

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

W S Post (WS)

Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH